
Advertise on podcast: EASL Podcasts
Rating
4from
This podcast has
168 episodes
Language
EnglishExplicit
No
Date created
2021/03/17
Latest episode
2026/11/11
Average duration
46 min.
Release period
11 days
Description
The EASL Podcast collection brings together Talk Liver to Me, EASL’s exclusive original podcast, alongside educational audio content adapted from EASL Studio, DeepDive webinars, and Policy Dialogues. Stay informed with expert insights, practical discussions, and the latest knowledge in hepatology — anytime, anywhere.
Unlock EASL Podcasts podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from EASL Podcasts podcast
Talk Liver To Me - Cholangiocarcinoma surveillance in PSC: What should we do now and what’s coming next?
2026/11/11
Discover how clinicians are approaching screening and surveillance in PSC today. From imaging and endoscopy to the promise of new biomarkers, this episode highlights key tools, ongoing challenges, and future directions in improving early detection of cholangiocarcinoma.
Host: Debbie Shawcross (King's College London)
Guests: Jesús Bañales (Donostia University Hospital), Gideon Hirschfield (The Autoimmune and Rare Liver Disease Programme)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-21
Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-21).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
EASL DeepDive: AI-Enabled Clinical Trials: Opportunities, Evidence and Oversight
2026/11/09
Artificial intelligence (AI) is opening new opportunities to improve the design, efficiency, and evidence generation of clinical trials. This EASL DeepDive examines its applications in patient selection, stratification, and trial workflows, as well as the emerging role of digital twins in simulating treatment responses. Particular attention is given to the use of AI-enabled real-world data to strengthen clinical evidence, while addressing questions of scientific validity, bias, and practical limitations.
Talk Liver To Me - Hepatocellular Carcinoma: Who to screen, when, and how?
2026/10/28
Hepatocellular carcinoma (HCC) surveillance is a cornerstone of liver disease management, yet uncertainty persists around who to screen, when to initiate surveillance, and which modalities to use. Evolving risk profiles and variation across guidelines have added complexity to clinical decision-making. In this podcast, we revisit the fundamentals of HCC screening, focusing on practical, evidence-based approaches to patient selection, timing, and surveillance strategies.
Host: Mattias Mandorfer (Medical University of Vienna)
Guests: Peter Jepsen (Aarhus University), Amit Singal (UT Southwestern Medical Center)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-20
Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-20).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
Talk Liver To Me - Psychohepatology: Are we overlooking mental health in liver disease care?
2026/10/14
This episode explores psychohepatology, examining the gut–liver–brain axis and the bidirectional links between liver disease and mental health. Discussion covers addiction biology, the impact of trauma and post-traumatic stress disorder (PTSD) on alcohol use, and the high prevalence of depression and anxiety in cirrhosis, highlighting integrated approaches to liver and mental health care.
Host: Mads Israelsen (Odense University Hospital)
Guests: Nicola Kalk (South London and Maudsley NHS Foundation Trust), Victoria Kronsten (King's College London)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-19
Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-19).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2026/10/09
This EASL Deep Dive explores key updates from the EASL Clinical Practice Guidelines on hepatocellular carcinoma (HCC), with a practical focus on diagnosis and treatment selection. Experts will discuss evolving imaging and diagnostic criteria, patient selection for surgery and locoregional therapies, and how to adapt management according to response to systemic treatment. The session will also highlight the growing importance of multidisciplinary, individualised care across the HCC treatment pathway.
Talk Liver To Me - Resmetirom and Semaglutide in MASH: Who, when and how to monitor?
2026/09/30
This episode of Talk Liver to Me explores the practical use of resmetirom and semaglutide in MASH, based on the 2026 EASL–EASD–EASO Guidance. Experts discuss who may benefit from treatment, when to initiate therapy, and how to monitor response and efficacy in clinical practice.
Host: Debbie Shawcross (EASL)
Guests: Andreea Ciudin (EASO), Amalia Gastaldelli (EASD), Frank Tacke (EASL)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-18
Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-18).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
Talk Liver To Me - Africa’s Liver Crisis: Why Is No One Talking About It?
2026/09/16
Liver disease represents a major and under-recognised public health challenge across Africa, driven by a complex interplay of viral hepatitis, rising metabolic dysfunction-associated steatotic liver disease, and a high burden of hepatocellular carcinoma (HCC). Despite this, awareness, surveillance, and access to care remain limited. In this podcast, we explore the evolving epidemiology of liver disease across the continent, highlighting key drivers, regional variations, and gaps in diagnosis and treatment. Why does the burden remain so under-recognised, and what are the priorities for prevention, early detection, and equitable care in Africa?
Host: Debbie Shawcross (King's College London)
Guests: Kwame Asomoah (University of Ghana Business School) and Wendy Spearman (University of Cape Town)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-17
Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-17).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
EASL DeepDive: Utility and challenges of genetic testing in PFIC
2026/09/14
This webinar explores the role of genetic testing in diagnosing Progressive Familial Intrahepatic Cholestasis (PFIC). Attendees will review key test types, understand the principles behind modern genomic technologies, and learn how to position these tests in the diagnostic approach of a person with a suspicion of PFIC and how to navigate common challenges in interpreting genetic results. The session will also highlight emerging trends shaping the future of genetic diagnostics in hepatology.
Learning objectives
Understand the genetic drivers of PFIC and the utility of their testing. Describe basic principles behind modern diagnostic genetic testing relevant to hepatology. Appropriately position genetic testing in the approach of a person suspected to have PFIC. Recognize common challenges in interpreting these genetic findings and linking them with the clinical presentation. Outline emerging trends influencing the future of genetic diagnostics in hepatology
This webinar has received educational grants from IPSEN. IPSEN has had no input into the programme, content, or faculty selection.
Talk Liver To Me - What are the Dos and Don'ts in Acute Liver Failure?
2026/09/02
Acute liver failure (ALF) is a rare but life-threatening condition requiring rapid recognition and decisive management. Early decisions around investigation, escalation, and referral can significantly impact outcomes. Despite advances in care, variation in practice and avoidable pitfalls remain common. In this podcast, we take a practical, case-based approach to the key “dos and don’ts” in ALF management, focusing on early diagnosis, initial stabilisation, appropriate investigations, and timely referral to specialist centres. What should clinicians prioritise, what should be avoided, and how can we optimise care in the critical early stages of acute liver failure?
Host: Mattias Mandorfer (Medical University of Vienna)
Guests: William Bernal (King's College London), Nigel Heaton (King's College London)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-16
Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-16).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
Talk Liver To Me - Endohepatology: Added value or added complexity?
2026/08/19
Endohepatology is emerging as a novel approach to liver disease assessment, with the potential to combine EUS-guided liver biopsy, portal pressure measurement, and variceal evaluation within a single session. This “one-stop shop” model could streamline diagnostic pathways and enable integrated, real-time clinical decision-making. However, this innovation comes at a time when hepatology is moving increasingly towards non-invasive testing strategies. Questions therefore remain around its appropriateness, clinical utility, and feasibility in routine practice. In this podcast, we explore whether this approach represents meaningful progress or premature adoption, examining current evidence, potential benefits, and practical challenges.
This episode is produced in collaboration with the European Society of Gastrointestinal Endoscopy (ESGE).
Host: Tom Marjot (King's College London)
Guests: Juan Abraldes (University of Alberta), Hannah van Malenstein (University Hospital Leuven)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-15
Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-15).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
Talk Liver To Me - What nobody tells you about starting a research group
2026/08/05
Early-career researchers and clinician-scientists play a central role in advancing hepatology research and innovation, yet the transition to independence often comes with challenges that extend beyond scientific expertise. Building a research programme, leading teams, securing funding, and developing a sustainable academic career require skills that are rarely addressed during formal training. In this podcast, we explore the realities of early academic leadership, focusing on the practical and professional challenges faced during the first years of research independence.
Host: Carolin Schneider (RWTH Aachen University)
Guests: Pierre-Emmanuel Rautou (Hôpital Beaujon, APHP & Université Paris Cité), Mathias Heikenwälder (University of Tübingen)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-14
Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-14).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
Talk Liver To Me - Global Updates on Hepatitis E: How Should We Manage Acute and Chronic Infection?
2026/07/22
Hepatitis E is a globally prevalent infection with diverse clinical manifestations, ranging from self-limiting acute hepatitis to chronic infection in immunosuppressed patients. Its presentation and epidemiology vary significantly between regions, influencing diagnostic and management strategies. Despite increasing recognition, uncertainty remains around who to test, when to treat, and how to manage chronic disease effectively. In this podcast, we bring together perspectives from Europe and Asia to explore key differences in clinical practice, emerging evidence, and practical approaches to care.
Host: Thomas Marjot (Kings College London)
Guests: Tobias Böttler (Universitätsklinikum Freiburg), Siddharth Sridhar (University of Hong Kong)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-13
Thank you to our healthcare industry partners for their support. For more information, please visit EASLCampus.eu.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-13).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
Talk Liver To Me - MASLD and HFpEF: Do We Need a Shared Treatment Strategy?
2026/07/08
Metabolic dysfunction-associated steatotic liver disease (MASLD) and heart failure with preserved ejection fraction (HFpEF) are increasingly recognised as manifestations of a shared cardiometabolic disorder. Driven by overlapping risk factors such as obesity and insulin resistance, these conditions frequently coexist and may interact through liver–heart crosstalk. Despite this, they are typically managed separately, with limited disease-specific therapies and suboptimal outcomes. In this podcast, we explore whether a more integrated approach could improve diagnosis, risk stratification, and treatment.
Host: Cyrielle Caussy (Lyon 1 University and Hospices Civils de Lyon)
Guests: Zannad Faiez (University of Lorraine, Nancy), Pinelopi Manousou (Imperial College London)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-12
Talk Liver To Me is supported by Opella. Opella has had no input to the content of this programme.
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-12).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
A joint EASL-ERN RARE-LIVER DeepDive – Wilson’s disease: a 2026 update
2026/07/03
The following objectives will be addressed in this EASL Deep Dive episode:
Have a profound knowledge of the pitfalls, limitations and difficulty of interpretation of the different tests of copper metabolism and liver copper assessmentsBe able to establish a diagnostic approach to Wilson’s disease, integrating clinical, laboratory, genetic and imaging toolsHave a good understanding of the different treatment modalities, how to position them in the disease course, how to monitor treatment and what to expect as a result/outcome?This EASL DeepDive webinar is supported by Orphalan and Univar Solutions. Orphalan and Univar Solutions have had no input into the content of this EASL DeepDive.
Talk Liver To Me - Chasing the perfect SLD preclinical model
2026/06/24
Steatotic liver disease (SLD) research relies heavily on preclinical models, yet no single model can fully capture the complexity of human disease. In this episode, we explore the new EASL position paper on preclinical SLD models. From MASLD and MetALD to organoids and precision-cut liver slices, we discuss the strengths, limitations, and translational relevance of today's most widely used models. How do we choose the right model, and are we any closer to finding the perfect one?
Based on EASL position paper on preclinical models of steatotic liver disease
Host: Rui Castro (University of Lisbon)
Speakers: Mathias Heikenwälder (University of Tübingen) and Suchira Gallage (University of Tübingen)
This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-11
This programme is intended for health care professionals only and is provided for educational purposes. EASL does not endorse or promote any medicinal products or medical devices. The views and opinions expressed are those of the speakers and do not necessarily reflect those of EASL.
All declarations of conflicts of interest are listed on EASL Campus (https://easlcampus.eu/tltm/episode-11).
EASL is not responsible for the accuracy of any translated versions of this podcast or of subtitles generated automatically by artificial intelligence.
Podcast sponsorship advertising
Start advertising on EASL Podcasts relevant audience podcasts
You may also like to advertise on these Podcasts

4.9328581397
REAL AF with Andy Frisella
Andy Frisella

3.99067574
20/20
ABC News

4.91366715
The Learning Leader Show With Ryan Hawk
Ryan Hawk

4.92110505
the bossbabe podcast
Natalie Ellis

4.3387182001
The Megyn Kelly Show
SiriusXM

4.947999419
The Shawn Ryan Show
Shawn Ryan

4.5185359
Who, When, Wow!
Tinkercast | Wondery

4.6688781131
Armchair Expert with Dax Shepard
Armchair Umbrella

4.9554862201
The MeidasTouch Podcast
MeidasTouch Network

4.639655
Only Murders in the Building Podcast
Straw Hut Media